Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.6.1.2 (
alanine aminotransferase
)
26,722
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Cysteine-rich intestinal protein
(
CRIP
) is a double zinc finger (LIM domain) protein that is developmentally regulated but has an unknown function.
CRIP
is highly expressed in the intestine, but expression is low in liver. To determine if
CRIP
expression is regulated under altered physiological status, we used CCl4-induced injury as a model to produce hepatic injury and systemic effects associated with inflammation. Since
CRIP
is a zinc finger protein and zinc decreases the hepatic response to CCl4, the effect of supplemental dietary zinc (300 mg/kg diet) was also examined. Our results show that this supplemental level of dietary zinc did not affect the index of hepatic injury (plasma
alanine aminotransferase
), indicating zinc did not have a protective effect. Liver
CRIP
mRNA increased with CCl4 and
CRIP
protein was shown by immunohistochemistry to be localized in hepatocytes near the vascular supply. In the intestine, CCl4 caused a transient decrease in
CRIP
mRNA, but supplemental dietary zinc treatment prevented this decrease. These current results show that
CRIP
expression changes in response to cellular damage due to acute hepatic injury and are consistent with a functional role for
CRIP
in proliferation, differentiation, or turnover.
...
PMID:Differential expression of cysteine-rich intestinal protein in liver and intestine in CCl4-induced inflammation. 892 91